Yahoo
Canadian Sec - Delayed Quote CAD

Green Thumb Industries Inc. (GTII.CN)

8.70 -0.30 (-3.33%)
At close: October 30 at 3:59:59 PM EDT
Chart Range Bar
Loading chart for GTII.CN
  • Previous Close 9.00
  • Open 9.00
  • Bid 8.68 x --
  • Ask 8.74 x --
  • Day's Range 8.65 - 9.00
  • 52 Week Range 7.40 - 14.39
  • Volume 104,577
  • Avg. Volume 149,960
  • Market Cap (intraday) 1.902B
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) 11.60
  • EPS (TTM) 0.75
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 21.03

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

www.gtigrows.com

4,900

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

GTII.CN
21.97%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

GTII.CN
8.71%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

GTII.CN
19.89%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

GTII.CN
65.68%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 306.68M
Earnings 4.88M
Profit Margin 1.59%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
5.0%
10.0%
15.0%
20.0%
25.0%

Analyst Insights

View More

Analyst Price Targets

17.88
21.03 Average
8.70 Current
24.92 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/10/2024
Analyst Wedbush
Rating Action Maintains
Rating Outperform
Price Action Raises
Price Target 15 -> 16

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.48%

  • Return on Assets (ttm)

    2.71%

  • Return on Equity (ttm)

    6.85%

  • Revenue (ttm)

    1.21B

  • Net Income Avi to Common (ttm)

    126.77M

  • Diluted EPS (ttm)

    0.75

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    283.59M

  • Total Debt/Equity (mrq)

    30.11%

  • Levered Free Cash Flow (ttm)

    151.48M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: